OXNARD, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced it has tapped Alex Katz to be the company
CURE Pharmaceutical Names Veteran Executive as Chief Financial Officer
